View Older Stories

Oct 12, 2026 04:06PM J&J's Tremfya shows fistula remission in Crohn's subgroups

Oct 12, 2026 04:05PM J&J's Tremfya shows sustained remission in Crohn's at 3 years

Oct 12, 2026 10:50AM Johnson & Johnson (JNJ) call put ratio 1 call to 1 put into quarter results

Oct 12, 2026 09:25AM Stifel Reiterates Hold Rating on Johnson & Johnson (JNJ)

Oct 12, 2026 06:27AM Johnson & Johnson (JNJ) call put ratio 1.5 calls to 1 put into quarter results

Oct 9, 2026 11:16AM Johnson & Johnson (JNJ) expiring October 9 weekly calls active into quarter results

Oct 9, 2026 07:01AM Johnson & Johnson releases 2-year psoriasis drug data at dermatology meeting

Oct 9, 2026 05:25AM Johnson & Johnson (JNJ) call put ratio 1.5 calls to 1 put into quarter results

Oct 8, 2026 05:37AM Johnson & Johnson (JNJ) call put ratio 1.6 calls to 1 put into quarter results

Oct 7, 2026 07:30AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)

Oct 6, 2026 05:59AM Johnson & Johnson (JNJ) PT Raised to $290 at RBC Capital

Oct 2, 2026 06:03AM J&J releases 2-year icotrokinra data for hard-to-treat plaque psoriasis

Sep 29, 2026 08:05AM J&J presents two-year IMAAVY data in adolescent myasthenia gravis

Sep 29, 2026 05:28AM Johnson & Johnson (JNJ) PT Raised to $278 at BofA Securities

Sep 22, 2026 09:29AM UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)

Sep 15, 2026 06:04AM J&J lung cancer drug combo shows low side effect rates in study

Sep 14, 2026 04:30AM Johnson & Johnson lung cancer drug shows 34-month survival in phase 3 trial

Sep 10, 2026 07:46AM Johnson & Johnson gets CE mark for Acuvue Oasys MAX 2-Week lens

Sep 8, 2026 08:02AM Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026

Aug 26, 2026 02:00PM FDA: issues early alert on Abiomed heart pump controller purge cassette issue

Aug 18, 2026 07:40AM Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)

Aug 12, 2026 08:32AM Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"

Aug 7, 2026 12:04PM Morgan Stanley tracks US drug market prescriptions for week ending July 31

Aug 6, 2026 07:39AM Johnson & Johnson (JNJ) PT Raised to $287 at Guggenheim

Aug 3, 2026 02:37PM Johnson & Johnson (JNJ) PT Raised to $280 at Raymond James

Aug 3, 2026 08:01AM Microsoft joins, Broadcom exits Goldman's top-stocks list

Aug 3, 2026 05:42AM Goldman Monthly Update to US Director's Cut List

Jul 28, 2026 06:04AM Johnson & Johnson (JNJ) call put ratio 1 call to 1 put unto J&J to settle ovarian talc claims

Jul 28, 2026 03:08AM Johnson & Johnson agrees to $5.5B settlement of ovarian talc claims

Jul 22, 2026 07:01AM FDA clears Johnson & Johnson's Ottava robotic surgical system

Jul 16, 2026 01:27PM Freedom Capital Upgrades Johnson & Johnson (JNJ) to Buy

Jul 16, 2026 08:49AM Johnson & Johnson (JNJ) PT Raised to $261 at Bernstein SocGen

Jul 16, 2026 06:40AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)

Jul 15, 2026 06:21AM Johnson & Johnson (JNJ) Tops Q2 EPS by 4c; raises guidance

Jul 15, 2026 03:00AM Johnson & Johnson Q2 earnings preview: analysts eye product launch progress

Jul 14, 2026 11:28AM Johnson & Johnson (JNJ) call put ratio 1.6 calls to 1 put into quarter results

Jul 14, 2026 06:41AM Johnson & Johnson (JNJ) call put ratio 1.5 calls to 1 put into quarter results

Jul 13, 2026 11:09AM Johnson & Johnson (JNJ) call put ratio 2.8 calls to 1 put into quarter results

Jul 7, 2026 10:31AM Increasing unusual put volume: AEVA SOLS LI TAP MTUM VSAT CMPS FPS CBRL JNJ NTAP

Jul 2, 2026 10:29AM Increasing unusual put volume: XLI EQT ARKG ROST WEN KOS BKLN UUP DB DJ JNJ LOW FVRR

Jun 29, 2026 04:33PM DePuy Synthes names Christina Zamarro as CFO, effective July 2026

Jun 26, 2026 12:35PM J&J presents new IMAAVY data for myasthenia gravis at EAN 2026

Jun 26, 2026 08:16AM Johnson & Johnson (JNJ) PT Raised to $270 at Guggenheim

Jun 17, 2026 11:15AM Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Jun 15, 2026 06:01AM Johnson & Johnson invests $1 billion in Jacksonville vision manufacturing

Jun 14, 2026 02:01PM Johnson & Johnson shows positive results for TALVEY-DARZALEX drug combination

Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day

Jun 11, 2026 07:45AM Johnson & Johnson expands US availability of TECNIS PureSee IOL

Jun 11, 2026 07:43AM Johnson & Johnson reports positive results for rare blood disorder treatment

Jun 10, 2026 11:22AM Johnson & Johnson faces $32 million verdict in Los Angeles asbestos case

View Older Stories